The therapeutic efficacy of (177)Lu-DOTATATE/DOTATOC in advanced neuroendocrine tumors: A meta-analysis

BACKGROUND: Somatostatin analog therapies showed great potential for patients suffering advanced neuroendocrine tumors (NETs). This study was aimed to evaluate the therapeutic efficacy of (177)Lu-DOTATATE/DOTATOC ((177)Lu-octreotate/octreotide) peptide receptor radionuclide therapy (PRRT) in advance...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Li-fan, Lin, Lin, Wang, Meng-jiao, Li, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478707/
https://www.ncbi.nlm.nih.gov/pubmed/32150065
http://dx.doi.org/10.1097/MD.0000000000019304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478707/
https://www.ncbi.nlm.nih.gov/pubmed/32150065
http://dx.doi.org/10.1097/MD.0000000000019304

Ejemplares similares